1-allyl-6-nitro-1H-indazole | 1193109-23-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡唑类
• 英文名称: 1-allyl-6-nitro-1H-indazole
• 英文别名: 1-Allyl-6-nitro-1H-indazole；6-nitro-1-prop-2-enylindazole
• CAS: 1193109-23-7
• 化学式: C₁₀H₉N₃O₂
• 分子量: 203.2
• InChiKey: ZKMVDNQJSRRRRA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  63.6
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-allyl-6-nitro-1H-indazole 、 2,5-己二酮 在 溶剂黄146 、 tin(ll) chloride 作用下， 以 四氢呋喃 为溶剂， 以80%的产率得到1-allyl-6-(2,5-dimethyl-pyrrol-1-yl)-1H-indazole
  参考文献：
  名称：

  One-pot synthesis of new 6-pyrrolyl- N -alkyl-indazoles from reductive coupling of N -alkyl-6-nitroindazoles and 2,5-hexadione

  摘要：

  One-pot synthesis of 6-pyrrolyl-N-alkyl-indazoles by the reductive coupling of N-alkyl-6-nitroindazoles and 2,5-hexadione was investigated in the presence of different reducing agents (SnCl2/AcOH and In/AcOH in THF). Indazoles 5a-h and 6a-h were obtained in good to excellent yields (74-95%) and characterized by elemental analysis, NMR, and single crystal X-ray diffraction. The same synthetic approach was also used to obtain 5-pyrrolyl-N-alkyl-indazoles. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2015.11.071
• 作为产物：
  描述：

  3-溴丙烯 、 6-硝基吲唑 在 caesium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以34%的产率得到1-allyl-6-nitro-1H-indazole
  参考文献：
  名称：

  Regioselective synthesis of 2H-indazoles through Ga/Al- and Al-mediated direct alkylation reactions of indazoles

  摘要：

  已开发出一种用于选择性合成2H-吲唑的高产率程序。

  DOI：

  10.1039/c5ob01747e

文献信息

• Substituted alkylamine derivatives and methods of use
  申请人：Amgen Inc.

  公开号：US20030225106A1

  公开（公告）日：2003-12-04

  Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  选定的胺对预防治疗疾病有效，如血管生成介导的疾病。本发明包括新的化合物、类似物、前药和药用可接受的盐，药物组合物和预防治疗疾病和其他疾病或状况的方法，包括癌症等。本发明还涉及制造这类化合物的过程以及在此类过程中有用的中间体。
• Substituted amine derivatives and methods of use
  申请人：Amgen Inc.

  公开号：US20030203922A1

  公开（公告）日：2003-10-30

  Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  选定的胺类化合物对于预防和治疗疾病，如血管生成介导的疾病，具有有效性。该发明涵盖了新颖的化合物、类似物、前药和其药用可接受盐，用于预防和治疗涉及癌症等疾病和其他疾患或病况的药物组合物和方法。该发明还涉及制备这些化合物的方法以及在这些方法中有用的中间体。
• Substituted arylamine derivatives and methods of use
  申请人：——

  公开号：US20020147198A1

  公开（公告）日：2002-10-10

  Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  所选化合物对预防和治疗疾病，如介导血管生成的疾病，具有有效性。该发明涵盖了新颖的化合物、类似物、前药和其药用可接受的衍生物，用于预防和治疗涉及癌症等疾病和其他疾病或情况的药物组合物和方法。该发明还涉及用于制备这种化合物的工艺，以及在这些工艺中有用的中间体。
• Synthesis and biological evaluation against <i>Leishmania donovani</i> of novel hybrid molecules containing indazole-based 2-pyrone scaffolds
  作者：M. El Ghozlani、L. Bouissane、M. Berkani、S. Mojahidi、A. Allam、C. Menendez、S. Cojean、P. M. Loiseau、M. Baltas、E. M. Rakib

  DOI：10.1039/c8md00475g

  日期：——

  A series of novel indazole–pyrone hybrids are synthesized and tested in vitro against both Leishmania donovani axenic and intramacrophage amastigotes.

  合成了一系列新型吲唑-吡喃酮杂交化合物，并对其进行了针对唐氏利什曼原虫轴突和滋养体内变形虫的体外测试。
• Substituted anthranilic amide derivatives and methods of use
  申请人：Amgen Inc.

  公开号：US20040087568A1

  公开（公告）日：2004-05-06

  Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  选定的化合物对于预防和治疗疾病，如介导血管生成的疾病具有有效性。该发明涵盖了新的化合物、类似物、前药和其药学上可接受的盐、药物组合物以及预防和治疗癌症等涉及疾病和其他疾病或状况的方法。该发明还涉及制备这些化合物的过程，以及在这些过程中有用的中间体。